$143.79 0.2 0.2%
Last Trade - 4:25pm
| Market Cap | £11.42bn |
| Enterprise Value | £12.54bn |
| Revenue | £3.26bn |
| Position in Universe | 702nd / 6846 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 03rd Jan | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2,105 | 2,116 | 2,257 | 2,778 | 2,884 | 3,783 | 4,377 | 3,684 | +12.4% | ||
| +16.0 | +10.0 | +27.1 | -15.4 | +28.9 | +149.6 | +41.1 | -35.8 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals. It provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its product under various brands, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, FragilEase, Genoglyphix, GSP, PG-Seq, PG-Find, Protein Clear, ProteinEXact and QSight, Glutomatic, Honigs Regression, HyperDSC, Inframatic, LAMBDA, NexION, NEN, OneSource, Opera Phenix, Operetta CLS and OsteoSense.
| Last Annual | January 3rd, 2021 |
| Last Interim | April 4th, 2021 |
| Incorporated | November 13, 1947 |
| Public Since | July 6, 1965 |
| No. of Shareholders: | 3,410 |
| No. of Employees: | 14,000 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector), |
| Exchange | New York Stock Exchange |
| Shares in Issue | 112,091,175 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 155 Federal St Ste 700, BOSTON, 02110-1727, United States |
| Web | http://www.perkinelmer.com/ |
| Phone | +1 781 6635776 |
| Contact | () |
| Auditors | Deloitte & Touche LLP |
As of 4:25pm, shares in PerkinElmer Inc are trading at $143.79, giving the company a market capitalisation of £11.42bn. This share price information is delayed by 15 minutes.
Shares in PerkinElmer Inc are currently trading at $143.79 and the price has moved by 56.09% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PerkinElmer Inc price has moved by 8.69% over the past year.
Of the analysts with advisory recommendations for PerkinElmer Inc, there are there are currently 4 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for PerkinElmer Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
PerkinElmer Inc is scheduled to issue upcoming financial results on the following dates:
The PerkinElmer Inc dividend yield is 0.2% based on the trailing twelve month period.
Last year, PerkinElmer Inc paid a total dividend of 0.28, and it currently has a trailing dividend yield of 0.2%. Looking ahead, shares in PerkinElmer Inc are due to go ex-dividend on 2021-07-15 and the next dividend pay date is 2021-08-06.
PerkinElmer Inc are due to go ex-dividend on 2021-07-15 and the next dividend pay date is 2021-08-06. The historic dividend yield on PerkinElmer Inc shares is currently 0.2%.
To buy shares in PerkinElmer Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in PerkinElmer Inc are currently trading at $143.79, giving the company a market capitalisation of £11.42bn.
Here are the trading details for PerkinElmer Inc:
Based on an overall assessment of its quality, value and momentum, PerkinElmer Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in PerkinElmer Inc are currently priced at $143.79. At that level they are trading at 9.76% discount to the analyst consensus target price of 0.00.
Analysts covering PerkinElmer Inc currently have a consensus Earnings Per Share (EPS) forecast of 9.518 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PerkinElmer Inc. Over the past six months, the relative strength of its shares against the market has been -4.17%. At the current price of $143.79, shares in PerkinElmer Inc are trading at 8.97% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The PerkinElmer Inc PE ratio based on its reported earnings over the past 12 months is 14.24. The shares are currently trading at $143.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
PerkinElmer Inc's management team is headed by:
Here are the top five shareholders of PerkinElmer Inc based on the size of their shareholding:
